Suchergebnisse - "Touzeau, Cyrille"

PubPharm (231)

31

Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03)

enthalten in: Clinical hematology international | 2023

von van de Wyngaert, Z. | Malard, F. | Hulin, C. | +12

32

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma : final analysis of PLEIADES and EQUULEUS

enthalten in: Blood cancer journal | 2023

von Moreau, P. | Chari, A. | Oriol, A. | +25

33

Phase 1 Study of the Combination of Escalated Total Marrow Irradiation Using Helical Tomotherapy and Fixed High-Dose Melphalan (140 mg/m²) Followed by Autologous Stem Cell Transplantation at First Relapse in Multiple Myeloma

enthalten in: International journal of radiation oncology, biology, physics | 2023

von Cailleteau, A. | Maingon, P. | Choquet, S. | +11

34

Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry

enthalten in: Blood cancer journal | 2023

von Noori, S. | Wijnands, C. | Langerhorst, P. | +11

35

BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival

enthalten in: Frontiers in oncology | 2023

von Champion, O. | Soler, A. | Maïga, S. | +6

36

Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma : final analysis of PLEIADES and EQUULEUS

enthalten in: Blood cancer journal | 07 March 2023

von Moreau, P. | Chari, A. | Oriol, A. | +25

37

Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation

enthalten in: Nature cancer | 2023

von Derrien, J. | Gastineau, S. | Frigout, A. | +11

ErratumIn: Nat Cancer. 2023 Sep 8;:. - PMID 37684528

38

Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study

enthalten in: British journal of haematology | 2022

von Landgren, O. | Weisel, K. | Rosinol, L. | +9

39

Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients : A Genome-Wide Transcriptome Analysis from the CASSIOPET Study

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2022

von Alberge, J. | Kraeber-Bodéré, F. | Jamet, B. | +16

40

All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients : final results of the phase II IFM 2013-06 study

enthalten in: Haematologica | 2022

von Touzeau, C. | Perrot, A. | Roussel, M. | +15